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Pertussis toxin was found to serve as a mitogen in the human T lymphocyte, an effect which could be mim- 
icked by its resolved binding component, the B oligomer. The mechanism of action of this component ap- 
peared to involve a rapid and sustained elevation of cytosolic calcium levels, as monitored by fura- fluores- 
cence. The source of mobilized calcium was predominantly extracellular, suggesting that the binding of the 
B oligomer to the T cell plasma membrane in some way elicited calcium channel activation. Notably, the 
influx of calcium was not observed with cholera toxin, an AB toxin lacking mitogenic effects on the human 
T lymphocyte. 
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1. INTRODUCTION 
The AB toxins, cholera and pertussis, have 
gained considerable popularity over the last decade 
as a result of their ability to ADP-ribosylate and so 
modify the function of certain guanine nucleotide- 
binding proteins (G-proteins) involved in the 
transduction of hormonal signals. Both toxins con- 
sist of a catalytic A subunit and a B, or binding, 
component. The A subunit is responsible for the 
ADP-ribosylation of G-protein substrates by vir- 
tue of its ability to catalyze the transferral of an 
ADP-ribose moiety from nicotinamide adenine 
dinucleotide (NAD) to certain residues on the 
target proteins. The B component is instrumental 
in providing the contact between the toxin and the 
cell plasma membrane which is necessary for the 
transfer of the A subunit into the cell. 
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Pertussis toxin, produced by the bacterium 
Bordetella pertussis, first gained recognition for its 
ability to produce certain in vivo responses in- 
cluding sensitization to histamine [ 11, hypoglyce- 
mia [2], and a leukocytosis associated with ele- 
vated levels of circulating lymphocytes [3,4]. The 
toxin consists of six subunits [5], the largest 
(28 kDa) of which is a catalytic moiety (the A 
subunit), while the other five, ranging in molecular 
mass from 9.3 to 23 kDa, are associated to form a 
pentameric binding component (the B oligomer). 
The suppression of inhibitory input to the ade- 
nylate cyclase system [6], as well as excitatory in- 
put to the phosphoinositide-phosphodiesterase 
system in certain cell types [7-91, are among the 
best documented effects of pertussis toxin-me- 
diated ADP-ribosylation. The efficacy of the A 
subunit in intact cells is dependent on the presence 
of the B oligomer, which appears to undergo 
bivalent binding to certain, currently unidentified 
receptors on the cell surface, so facilitating trans- 
fer of the A subunit across the plasma membrane. 
However, evidence that. in certain cell systems, the 
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B oligomer may play a more active role in the 
modulation of cellular functions has been provided 
by Tamura et al. [lo] who found that the resolved 
B oligomer of pertussis toxin stimulated mitosis in 
murine splenocytes and enhanced glucose oxida- 
tion in rat adipocytes. Despite the important im- 
plications of these findings with respect to the 
lymphocytosis-promoting [3,4] and hypoglycemic 
[2] physiological effects of the toxin, the 
mechanism of action of B-oligomer-mediated 
responses has remained undefined. 
Recent evidence from our laboratory suggests 
that pertussis toxin-induced proliferation in the 
human T lymphocyte is attributable to an action of 
the B oligomer and occurs by means of a calcium- 
dependent transduction process. This finding 
raises interesting questions regarding the nature of 
the pertussis toxin receptors and their possible 
significance in normal proliferative events. 
2. MATERIALS AND METHODS 
The following materials were purchased from 
the sources indicated: pertussis toxin and cholera 
toxin from List Biological Laboratories (Camp- 
bell, CA), fura- acetoxy methyl ester from 
Calbiochem-Behring (San Diego, CA), [3H]thymi- 
dine from New England Nuclear (Boston, MA), 
OKT3 from Ortho Diagnostics (Rahway, NJ) and 
interleukin 2 from Cetus (Emeryville, CA). The 
resolved B oligomer of pertussis toxin was a gift 
from Dr Drusilla Burns of the Division of Bacterial 
Products, Food and Drug Administration [l 11. 
T lymphocytes were isolated from human 
peripheral blood obtained from normal healthy 
volunteers. The diluted whole blood was subjected 
to centrifugation on a Ficoll-Hypaque density gra- 
dient. T lymphocytes were separated from con- 
taminating monocytes and B cells by a plastic 
adherence procedure followed by the passage of 
cells through a nylon wool column. 
For proliferation studies, cells were incubated at 
5 x 10’ cells per well in the presence of the in- 
dicated concentrations of the stimuli in question. 
After 48-72 h, the cells were pulsed for 4 h with 
1 ,&i/well of [3H]thymidine. At the end of the 
pulse, cells were collected on glass fibre filter paper 
and counted for radioactivity in a Beckman LS 
1801 liquid scintillation spectrometer. 
For the purposes of intracellular calcium 
measurement, cells were loaded with the fluores- 
cent calcium chelator, fura- [12], by means of a 
60 min preincubation at 37°C with the membrane- 
permeant acetoxy methyl derivative of the dye at 
1 mM. At the end of the incubation, cells were 
washed, resuspended in RPM1 1640 and stored on 
ice in 1 ml aliquots of approx. 20 x lo6 cells. Im- 
mediately prior to use, each sample was 
sedimented in a microfuge and resuspended in 2 ml 
of a simplified saline solution, pre-warmed to 
37°C. Calcium measurements were conducted in a 
Spex model CM-2 cation measurement system, 
with dual excitation at 340 and 380 nm. Emission 
was monitored at 505 nm. Fluorescence intensity 
ratios were converted to calcium concentrations 
using a revised version of the Spex CMPROG. 
3. RESULTS AND DISCUSSION 
Pertussis toxin was found to induce the pro- 
liferation of human T lymphocytes at concentra- 
Table 1 
T lymphocyte proliferation in response to AB toxins or 
their components 
Condition 
(g/ml) 
Control 
Pertussis toxin 
AB (5 x lo-‘) 
AB (5 x lo-*) 
AB (5 x 10-9) 
B (5 x lo-‘) 
B (5 x 1O-8) 
B (5 x 10-9) 
[3H]Thymidine 
incorporation (cpm) 
432 -t 32 
2817 +_ 11 
456 + 33 
380 f 9 
6905 + 53 
298 k 9 
326 + 17 
Control 431 k 19 
Cholera toxin 
AB (5 x lo-‘) 264 k 19 
AB (5 x 1O-8) 268 -t 35 
AB (5 x 10-9) 557 f 56 
T lymphocytes were treated with the indicated 
concentrations of the pertussis toxin holotoxin (AB), the 
cholera toxin holotoxin (AB), and the B oligomer of 
pertussis toxin (B) over a 72 h time interval. The data 
shown represent the means f SD for triplicate 
determinations from a single experiment which is 
representative of at least three 
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tions of 0.5 pg/ml (table 1). Lower concentrations 
proved to be non-mitogenic. In view of reports of 
a pertussis toxin-mediated ADP-ribosylation of a 
41 kDa protein in the T lymphocyte [ 131, it was 
desirable to determine whether or not the 
mitogenic properties of the holotoxin could be 
unequivocally dissociated from ADP-ribosylation 
events. This was achieved through use of the 
purified B oligomer. The observation that the B 
oligomer, alone, at concentrations of 0.s pg/ml 
was efficacious as a mitogenic stimulus obviated a 
role for ADP-ribosylation in pertussis toxin- 
mediated proliferation (table 1). Notably, the pro- 
liferative properties of pertussis toxin and its B 
oligomer could not be mimicked by cholera toxin. 
In an effort to characterize the mechanism of ac- 
tion of pertussis toxin and its B oligomer as 
mitogens, cytosolic calcium levels in T lym- 
phocytes were monitored by means of the in- 
tracellular calcium indicator, fura-2. Exposure of 
cells to mitogenic concentrations of either pertussis 
toxin or its resolved B oligomer resulted in a 
gradual and sustained elevation of cytosolic 
calcium concentrations (fig. 1). The calcium 
mobilization response appeared to be minimally 
dependent on intracellular calcium, being for the 
most part abolished upon chelation of extracellular 
calcium by 1 mM EGTA. EGTA was added to T 
cell suspensions for 1 min prior to administration 
of the stimuli so as to achieve depletion of ex- 
tracellular calcium without appreciably affecting 
the intracellular stores. In accordance with the pro- 
liferation data, fairly high concentrations of per- 
tussis toxin were required for an appreciable 
calcium signal with approx. 0.1 pg/ml of the toxin 
proving to be the threshold and 5 pg/ml providing 
the maximal response (fig.2). Notably, calcium 
mobilization was observed for the mitogenic per- 
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Fig. 1. Fluorescence tracing obtained by stimulation of fura-Zloaded T lymphocytes with (A) 0.5 pg/ml pertussis toxin, 
(B) 0.5 pg/ml pertussis toxin following a 1 min preincubation with 1 mM EGTA, (C) 0.5 pg/ml B oligomer, and (D) 
0.5 pg/ml B oligomer following a 1 min preincubation with 1 mM EGTA. The arrows indicate the time of addition of 
the agents in question. The tracings shown were obtained from a single experiment which was representative of at least 
three. 
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Fig.2. Fluorescence tracings obtained by exposure of fura-2-loaded T lymphocytes to a range of concentrations of the 
B oligomer of pertussis toxin. The arrow indicates the time of addition of the stimulus. The tracings shown were 
obtained from a single experiment which was representative of at least three. 
tussis holotoxin and its B oligomer, but not for the 
non-mitogenic AB toxin, cholera toxin (fig.3). 
Unlike the cholera toxin-binding site, which has 
been identified as the GM~ monosialoganglioside 
[ 14,151, the membrane components responsible for 
pertussis toxin binding remain to be defined. The 
steep dose-response requirements for the mitogenic 
effect may suggest the importance of the extensive 
aggregation of these receptor molecules for effec- 
tive transduction of the mitogenic signal. The 
structural properties of the toxin are consistent 
with such a model. The pentameric B oligomer ap- 
pears to be assembled from two dimeric entities 
joined through a connecting C subunit [lo]. In- 
teraction of each dimer with an independent 
recognition site would result in a bivalent binding 
phenomenon. Upon dissociation of the B oligomer 
into its constituent dimers in the presence of urea, 
the mitogenic properties of the toxin are lost, even 
though the dimers retain their ability to compete 
with the holotoxin for binding sites [lo]. The 
divalent attachment of the intact B oligomer could 
conceivably result in the cross-linking of receptor 
sites in a manner analogous to that seen with plant 
lectins. Notably, lectin-induced mitogenesis is 
likewise associated with changes in cytosolic free 
calcium levels [16,17]. 
The near absolute dependency of pertussis toxin- 
induced calcium mobilization on the presence of 
extracellular calcium implicates the opening of 
calcium channels as an important event in the 
transduction process activated by the binding 
event. Whether this calcium influx is attributable 
to the generation of a second messenger substance 
derived from the phosphoinositide turnover cycle 
[ 181 or perhaps to more direct interactions between 
the toxin-binding sites and channel complexes is a 
matter currently under investigation. In an effort 
to elucidate further the molecular mechanisms in- 
volved in pertussis toxin-stimulated mitogenesis, 
o’, , , , , , , 1 , 
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Fig.3. Fluorescence tracing obtained by exposure of 
fura-Zloaded T lymphocytes to 0.5 pg/ml cholera toxin. 
The arrow indicates the time of addition of the toxin. 
The tracing shown was obtained from a single 
experiment which was representative of at least three. 
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we are presently conducting studies of 
phosphoinositide turnover and protein kinase C 
activation in the pertussis toxin-stimulated T lym- 
phocyte. 
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